Start the conversation
ECO Animal Health PLC (LSE: EAH) - the U.K. biotech that's declared war on the "Super Bug" threat - saw its shares zoom more than 12% today after the company said it would beat estimates for fiscal 2017 revenue and "significantly" beat profit forecasts.
And this is just the beginning.
This company has at least four big "triggers" working in its favor. Any one of them would be enough to turn this stock into a moneymaker. The fact that there are three - working together - means ECO Animal Health should be one of the best biopharmaceutical plays to ride for at least the rest of this year.
Let me show you why...
This is premium content for Private Briefing subscribers only.